PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Rheumatology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.\', \'Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.\', \'Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.\', \'FRS(T), the Royal Society of Thailand, Sanam Sueapa, Dusit,Bangkok, Thailand.\', \'Mahachakri Sirindhorn Clinical Research Center, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand wonngarm.k@chulacrc.org.\', \'Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.\', \'Renal Immunology and Transplantation Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e00201910.1136/rmdopen-2021-002019
?:hasPublicationType
?:journal
  • RMD open
is ?:pmid of
?:pmid
?:pmid
  • 34862313
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.169
?:rankingScore_hIndex
  • 13
is ?:relation_isRelatedTo_publication of
?:title
  • Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all